HALO
Halozyme Therapeutics Inc.
$65.19
+$0.56(+0.87%)
55
Overall
60
Value
50
Tech
--
Quality
Market Cap
$7.50B
Volume
1.41M
52W Range
$42.01 - $79.50
Target Price
$75.56
Key Metrics Overview
| Market Cap | $7.50B | P/E Ratio | 11.12 |
| 52W High | $79.50 | 52W Low | $42.01 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 7.0% | 52W Position | 61.8% |
| Overall Score | 55 | Value Score | 60 |
| Quality Score | -- | Technical Score | 50 |
Growth Analysis
| EPS Current Est | $5.86 | EPS Next Est | $7.29 |
| EPS Growth Est | +24.4% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HALO | $65.19 | +0.9% | 1.41M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Halozyme Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW